Welcome to LookChem.com Sign In|Join Free

CAS

  • or

503040-74-2

503040-74-2

Post Buying Request

503040-74-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

503040-74-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 503040-74-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,3,0,4 and 0 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 503040-74:
(8*5)+(7*0)+(6*3)+(5*0)+(4*4)+(3*0)+(2*7)+(1*4)=92
92 % 10 = 2
So 503040-74-2 is a valid CAS Registry Number.

503040-74-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Methyl-5-nitro-1,3-benzothiazol-2-amine

1.2 Other means of identification

Product number -
Other names 2-Oxazolamine,4,5-dihydro-N,5-dimethyl-N-phenyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:503040-74-2 SDS

503040-74-2Upstream product

503040-74-2Relevant articles and documents

Inhibitors of histone deacetylase

-

, (2008/06/13)

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Inhibitors of histone deacetylase

-

, (2008/06/13)

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 503040-74-2